ARUP Institute for Research and Innovation in Diagnostic and Precision MedicineTM
The ARUP R&I Institute combines scientific expertise with advanced laboratory capabilities to accelerate breakthroughs in diagnostic medicine. We provide regulatory support, custom assay development, and operational solutions that transform ideas into validated, scalable technologies.
Our Capabilities
Custom Assay Development
Tailored moderate-to-complex assay development addresses unique clinical, research, and regulatory needs. The ability to introduce high-throughput optimization, including robotics and automated workflows, ensures scalability, reliability, and cost-effectiveness.
New Technology Evaluation
Comprehensive, evidence-driven evaluations of emerging diagnostic technologies, including new platforms, testing methodologies, and innovative laboratory solutions
At-Home Collection Studies and Capillary Microcollection Testing
Testing that enables decentralized research studies and patient-friendly sample collections with minimal sample volumes without compromising quality
Advanced Bioresources
High-quality specimens and biorepository services offered for research and validations, long- and short-term sample storage, and specialty specimen processing
IVD 510(k) Support: Registrational, De Novo, and Premarket Approval (PMA)
Comprehensive analytic and clinical validation services that streamline FDA clearance
Consultation Services
Expert guidance on validation protocols and regulatory strategy and compliance provided by more than 100 medical directors, who are leading researchers and faculty at the Spencer Fox Eccles School of Medicine at the University of Utah
Subspecialty Expertise
Deep subspecialty expertise spans a broad range of laboratory technologies, including molecular flow cytometry, cytogenetics and fluorescence in situ hybridization (FISH), immunoassays, clinical chemistry, hematology, and more
Our Innovation Approach

We are at the cusp of remarkable, landscape-altering technologies, and we are in a position to grasp that future and bring it to the present.”
Tracy George, MD, ARUP Chief Scientific Officer and President of the Innovation Business Unit
The Sherrie Perkins Research and Innovation Collaboration Grant
The Sherrie Perkins Grant empowers innovators to push boundaries and drive diagnostics advancements that shape the next generation of patient care.




















